It shouldn’t be a surprise that biotechs have already been in touch with Novartis to see whether they can jump onto the Swiss pharma’s T-Charge platform.
[Fierce Biotech]
Home Newsletters Cell Therapy News Taking Charge—Biotechs Already Approaching Novartis to Partner on ‘Game Changing’ CAR-T Platform
